Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 15 , ISSUE 2 ( March-April, 2023 ) > List of Articles


Challenging Presentations of Retained Products of Conception: A Case Series

Shehla Jamal, Natasha Singh

Keywords : Abnormal uterine bleeding, Abortion, Retained product of conception

Citation Information : Jamal S, Singh N. Challenging Presentations of Retained Products of Conception: A Case Series. J South Asian Feder Obs Gynae 2023; 15 (2):230-233.

DOI: 10.5005/jp-journals-10006-2207

License: CC BY-NC 4.0

Published Online: 11-05-2023

Copyright Statement:  Copyright © 2023; The Author(s).


A fraction of the trophoblastic tissue that remains in the uterus after an abortion or a full-term vaginal delivery is referred to as “retained products of conception” that can have varied manifestations like persistent vaginal bleeding, acute abnormal uterine bleeding (AUB), abdominal pain, sepsis, chronic pelvic pain, shock, pyometra, hematometra and in long tern may lead to subfertility and secondary amenorrhea. Due to absence of diagnostic clues, resulted in missed or delayed diagnosis that further lead to trial therapies, thus possess a challenge to treating physician. The diagnostic modalities may include ultasonography with color Doppler, hysteroscopy, but the gold standard test is histopathological examination (HPE). We present unusual clinical presentations of retained POCs at our center for the benefit of widening the diagnostic horizon of this particular pregnancy complication.

PDF Share
  1. van den Bosch T, Daemen A, Van Schoubroeck D, et al. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med. 2008;27(3):357–361. DOI: 10.7863/jum.2008.27.3.357.
  2. Abbasi S, Jamal A, Eslamian L, et al. Role of clinical and ultrasound findings in the diagnosis of retained products of conception. Ultrasound Obstet Gynecol 2008;32(5):704–707. DOI: 10.1002/uog.5391.
  3. Dyer I, Bradburn DM. An inquiry into the etiology of placental polyps, Am J Obstet Gynecol 1971;109(6):858–867. DOI:
  4. Yu D, Wong YM, Cheong Y, et al. Asherman syndrome–one century later. Fertil Steril 2008;89(4):759–779.
  5. Smorgick N, Levinsohn-Tavor O, Ben-Ami I, et al. Hysteroscopic removal of retained products of conception following first trimester medical abortion. Gynecol Minim Invasive Ther 2017;6(4):183–185. DOI: 10.1016/j.gmit.2017.05.002.
  6. Hooker AB, Aydin H, Brolmann HA, et al. Long-term complications and reproductive outcome after the management of retained products of conception: A systematic review. Fertil Steril 2016;105(1):156–164.:e151. DOI: 10.1016/j.fertnstert.2015.09.021.
  7. Garg N, Bhatti SG, Garg S. Importance of Placental Sonogram in the First Trimester for Early Detection of Abnormal Placentation. J South Asian Feder Obst Gynae 2020;12(3):133–136.
  8. Milstein KK, Milstein PS. Psychophysiologic aspects of denial in pregnancy. Case report. J Clin Psychiatry 1983;44:189–190.
  9. Wessel J, Endrikat J. Cyclic menstruation-like bleeding during denied pregnancy. Is there a particular hormonal cause?. Gynecological Endocrinology. 2005;21(6):353–359.
  10. Tinelli AP, Haimovich S. Hysteroscopy. New York, NY: Springer Berlin Heidelberg, 2017.
  11. Ustunyurt E, Kaymak O, Iskender C, et al. Role of transvaginal sonography in the diagnosis of retained products of conception. Arch Gynecol Obstet 2008;277:151–154. DOI: 10.1007/s00404-007-0436-z.
  12. Kamaya A, Petrovitch I, Chen B, et al. Retained products of conception: Spectrum of color Doppler findings. J Ultrasound Med 2009;28(8):1031–1041. DOI: 10.7863/jum.2009.28.8.1031.
  13. Tigga M, Manoli N. Uterine Arteriovenous Malformation as a Cause of Secondary Postpartum Hemorrhage: A case report. J South Asian Feder Obs Gynae 2020;12(3):188–191. DOI: 10.1007/s00404-022-06498-0.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.